Droperidol (Hospira, Inc.)


Welcome to the PulseAid listing for the Droperidol drug offered from Hospira, Inc.. This Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: DROPERIDOL
SUBSTANCE NAME: DROPERIDOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1988-02-29
END MARKETING DATE: 0000-00-00


Droperidol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDroperidol from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/mL)
START MARKETING DATE: 1988-02-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1187_dbe5ebe3-9ef5-4cf7-b00d-c178c9a518e2
PRODUCT NDC: 0409-1187
APPLICATION NUMBER: ANDA071981

Other DROPERIDOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Droperidol
Cardinal HealthDroperidol
Hospira, Inc.Droperidol